Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05019144 · ClinicalTrials.gov registry record · NA
Telemedicine Optimized Burn Intervention
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT05019144 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 130 participants.
The verdict
NCT05019144, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
Because burn patients and their caregivers often live long distances from regional burn centers, access to expert burn care is limited, resulting in a negative effect on adherence to treatment and a higher risk of wound complication. A novel smartphone application synchronized with a web portal for providers, called the Telemedicine Optimized Burn Intervention (TOBI), was recently developed to enable burn experts to direct burn wound care while the patient and caregiver are home through text messaging, image transfer, and video-conferencing. The goal of the present study is evaluate TOBI compared to face-to-face care as usual for pediatric patients/caregivers visiting a burn center. This study will also assess the feasibility of conducting a larger-scale clinical trial in several burn centers. The app will allow the physician and patient/caregivers to make instant decisions regarding treatment, allowing for "turn on a dime" treatment decisions, rather than having the patients and families wait for scheduled clinic appointments, often hours away from home. This "on demand" medical care takes an innovative approach to increasing access to burn experts through smartphone technology and addressing adherence to prescribed treatment by increasing communication between provider and patients.
Interventions
- PROCEDURE Face-to-face burn care
- PROCEDURE Telemedicine enhanced burn care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05019144
The ClinicalTrials.gov registry entry for NCT05019144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Face-to-face burn care is the first listed.
NCT05019144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05019144 about?
NCT05019144 is a clinical study titled "Telemedicine Optimized Burn Intervention". Because burn patients and their caregivers often live long distances from regional burn centers, access to expert burn care is limited, resulting in a negative effect on adherence to treatment and a higher risk of wound complication. A novel smartphone application synchronized with a web portal for ...
What is the current status of trial NCT05019144?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-06-01. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT05019144?
The interventions under investigation include: Face-to-face burn care (PROCEDURE), Telemedicine enhanced burn care (PROCEDURE).
Who is sponsoring clinical trial NCT05019144?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.